CD209 and HIV infectious disease: A different mannose-based glycomimetic, Polyman26, already known to inhibit DC-SIGN-mediated HIV infection of CD8+ T cells, was also able to inhibit Spike protein binding to DC-SIGN, leading to a decrease in trans-infection of DC-SIGN-expressing cells [100].